The main focus of the Minna Lab is translational (“bench to bedside”) cancer research aimed at developing new ways to diagnose, prevent, and treat lung cancer based on a detailed understanding of the molecular pathogenesis of lung cancer.
Dr. Minna, and his long-time collaborator Dr. Gazdar (who passed away in 2018), have a long history as world leaders in lung cancer translational research and have developed hundreds of lung cancer lines which are used worldwide in this research.
